UPDATE 1-India Wockhardt gets U.S. nod for anti-fungal drug
(Adds details)
MUMBAI, May 31 (Reuters) - Indian drug maker Wockhardt (WCKH.BO) said on Thursday it had received tentative approval from U.S. Food and Drug Administration to sell terbinafine, a generic version of anti-fungal drug Lamisil sold by Novartis (NOVN.VX).
"The U.S. market for terbinafine tablets is about $680 million," Wockhardt Chairman Habil Khorakiwala said in a statement.
Wockhardt currently sells 20 other products in the United States, the statement said.
Shares in Wockhardt closed 1.4 percent down at 414.75 rupees in a Mumbai market that rose 0.9 percent.
((Reporting by Devidutta Tripathy and Swati Bhat, editing by John Mair; Reuters Messaging: devidutta.tripathy.reuters.com@reuters.net; +91 22 6636 9031)) Keywords: WOCKHARDT INDIA/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM283361
